Rigel Pharmaceuticals Inc

2026-11-12 21:07; UTC

Rigel Pharmaceuticals, Inc. shares advanced during Thursday's session, despite earlier pulling back, following the release of disappointing earnings for the year ending September 2026.

2026-11-10 21:07; UTC

Rigel Pharmaceuticals CEO Raul Rodriguez will present at the Jefferies Global Healthcare Conference on November 17, 2026, discussing therapies for hematologic disorders and cancer.

2026-11-09 21:03; UTC

Rigel Pharmaceuticals, Inc. shares rose sharply after Citigroup maintained a Buy rating and raised its price target to $86 from $83, amid high trading volume.

2026-11-06 21:02; UTC

Rigel Pharmaceuticals reported Q3 EPS of $0.65, below the $0.96 estimate, and adjusted FY 2026 sales guidance to $290M-$295M, missing expectations.

2026-11-05 23:56; UTC

Rigel Pharmaceuticals reports Q3 2026 net income of $13.2 million, missing expectations, and revises full-year revenue guidance down to $290-$295 million.

2026-11-04 21:07; UTC

Rigel Pharmaceuticals will present updated data from its Phase 1b clinical study of R289 at the American Society of Hematology Annual Meeting on December 12, 2026.

2026-11-03 21:07; UTC

Rigel Pharmaceuticals, Inc. shares are declining, continuing a trend of weaker performance over the past three sessions amid overall market volatility.

2026-11-02 20:56; UTC

Rigel Pharmaceuticals, Inc. shares fell over one percent after pulling back from an earlier session high, though they remain above the 20-day moving average.

2026-10-30 23:06; UTC

Rigel Pharmaceuticals, Inc. shares declined sharply during after-market hours, reaching their lowest point since Friday's close amid a broader market decline.

2026-10-29 21:02; UTC

Rigel Pharmaceuticals, Inc. is declining in after-market trading, falling significantly since Thursday's close.

2026-10-22 20:07; UTC

Rigel Pharmaceuticals Inc's shares are slightly higher, maintaining a position above the 20-day moving average amid broader market gains.

2026-10-21 20:07; UTC

Rigel Pharmaceuticals Inc. shares advanced on Wednesday, continuing a trend of higher daily finishes and remaining above their 20-day moving average.

2026-10-20 20:08; UTC

Rigel Pharmaceuticals Inc will present pooled efficacy and safety data from two clinical trials of GAVRETO® at the European Society For Medical Oncology Congress on October 25, 2026.

2026-10-19 20:07; UTC

Rigel Pharmaceuticals reported positive GAVRETO data at ESMO, showing a 53% overall response rate in RET fusion-positive solid tumors, with HC Wainwright reiterating a Buy rating.

2026-10-15 19:56; UTC

Rigel Pharmaceuticals Inc is trading higher, rebounding after three sessions of declines, supported by strength in the broader biotechnology sector.

2026-10-14 21:31; UTC

Rigel Pharmaceuticals Inc is experiencing a significant decline in after-market trading, continuing a trend of four consecutive sessions finishing lower.

2026-10-13 19:16; UTC

Rigel Pharmaceuticals Inc shares fell, continuing a notable decline since Monday's close amid unusual activity, with prices around the middle of their one-month range.

2026-10-08 20:01; UTC

Rigel Pharmaceuticals Inc is trading higher, reaching a peak return after initial declines, currently above its 20-day moving average and near the upper end of its one-month range.

2026-10-07 20:01; UTC

Rigel Pharmaceuticals Inc is seeing a higher trading session today, marked by unusually high share volume, diverging from its recent upward trend since Tuesday.

2026-10-06 20:06; UTC

Rigel Pharmaceuticals Inc shares fell sharply, continuing a downward trend since Monday, with the price remaining well below its 20-day moving average.

2026-10-05 21:01; UTC

Rigel Pharmaceuticals Inc is trading lower in after-market hours, extending a decline that started at Monday's close amid a notably quiet session.

2026-10-01 20:07; UTC

Rigel Pharmaceuticals Inc shares fell sharply, closing significantly lower amid consistent pressure and a four-session losing streak below the 20-day moving average.

2026-09-24 20:07; UTC

Rigel Pharmaceuticals Inc shares fell, continuing a downward trend since Wednesday, despite a midday recovery, remaining below their opening level.

2026-09-23 20:07; UTC

Rigel Pharmaceuticals Inc shares fell sharply amid a declining broader market, reaching a low of nearly 3.75% below Tuesday's close before a slight recovery.

2026-09-18 20:02; UTC

Rigel Pharmaceuticals Inc is advancing today with unusually high trading activity, breaking from a recent trend of higher daily closes since Thursday.

2026-09-15 20:02; UTC

Rigel Pharmaceuticals is trading lower as the NY Empire State Manufacturing Index fell sharply, raising concerns about economic contraction in New York's manufacturing sector.

2026-09-11 19:46; UTC

Rigel Pharmaceuticals is higher today, influenced by CPI data and speculation about potential Federal Reserve interest rate hikes. The stock remains near its one-month trading range.

2026-09-10 23:21; UTC

Rigel Pharmaceuticals Inc is rising in after-market trading, reversing a three-session decline. No specific news was identified to explain this price action.

2026-09-08 20:07; UTC

Rigel Pharmaceuticals Inc shares are lower today, continuing a decline since Friday. The stock saw notable volatility but remains above its 20-day moving average.

2026-09-01 20:08; UTC

Rigel Pharmaceuticals Inc shares are higher today, reflecting strong market performance and robust momentum above the 20-day moving average. No specific news was identified.